Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050762 · ClinicalTrials.gov registry record
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
A clinical trial of Endocrine Disease, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT03050762 is a study of Endocrine Disease that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 15,000 participants, above the 1,029-participant average among 4 other Endocrine Disease trials with a reported enrollment target (1358% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03050762, a study of Endocrine Disease, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
Conditions Studied
Interventions
- OTHER Data Collection
- BEHAVIORAL Follow Up
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2011-10-05 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03050762
The ClinicalTrials.gov registry entry for NCT03050762 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,029-participant average among 4 other Endocrine Disease trials with a reported enrollment target (1358% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endocrine Disease appearing as the primary indexed condition, and to 2 interventions - of which Data Collection is the first listed.
NCT03050762 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03050762 about?
NCT03050762 is a clinical study titled "Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease". The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
What is the current status of trial NCT03050762?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2011-10-05. Estimated completion is 2027-10.
What conditions does trial NCT03050762 study?
This clinical trial studies the following conditions: Endocrine Disease.
What interventions are being tested in trial NCT03050762?
The interventions under investigation include: Data Collection (OTHER), Follow Up (BEHAVIORAL).
Who is sponsoring clinical trial NCT03050762?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03050762 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endocrine Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Endocrine-Related Conditions and Physiology
RECRUITING
-
Diagnosis of Pheochromocytoma
RECRUITING · Phase 1
-
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
COMPLETED · Phase 2
-
Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.